Insider sale
CORBUS PHARMACEUTICALS HOLDINGS, INC.
$171.4K
17K shares
What this filing means
STIFEL, NICOLAUS & COMPANY, INC CIAS /FA plans to sell 17K shares of CORBUS PHARMACEUTICALS HOLDINGS, INC. valued at approximately $171.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/7/2026ACC: 0001972481-26-000254
→
17K
Shares to sell
$171.4K
Approx. market value
17K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Units
Equity Compensation
1/31/2026
7.79KRestricted Stock Units
Equity Compensation
2/12/2025
9.21KTotal acquired17K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2026 | Restricted Stock Units Equity Compensation | 7.79K | — |
2/12/2025 | Restricted Stock Units Equity Compensation | 9.21K | — |
| Total | 17K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
17K
Market value
$171.4K
8/7/2026
Total
Units
17K
Value
$171.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/7/2026 | 17K | $171.4K | Nasdaq | Planned |
| Total | 17K | $171.4K | ||